Canada Spends Logo

Explore our Budget 2026 analysis

Grant: Proof of Principle Program - Phase I

Université Laval

$160,000.00

A Novel Class of Drug Treatment Against Chronic Constipation in Spinal Cord-Injured People

FY 2012-13

Summary
Spinal cord injury (SCI) is a devastating condition leading to immediate and irreversible paralysis below injury level. Patients with SCI suffer also from severe health problems including bladder and bowel dysfunctions. Although, some approaches or devices are currently used to treat occasional constipation in the general population, those same approaches are generally considered as inefficient or unsafe when chronically used against chronic constipation. We obtained evidence suggesting that some unsuspected classes of molecules could be used to trigger episodes of defecation in SCI patients. We propose experiments that will enable the selection of the best molecule(s)among them. This may pave the way to a novel class of pills specifically designed to safely and efficiently treat chronic constipation in SCI patients.
Program
Proof of Principle Program - Phase I
Location
Quebec, Canada
Recipient Type
Academia
Type
Grant
Source
CIHR Funding Decisions Database

As published

Id
282874
Name
Guertin Pierre
Region
Québec
Country
Canada
Orgtype
Institution Paid; Research Institution
Instname2
Neurosciences, Mental Health and Addiction
Theme2
Biomedical
Prcname2
Proof of Principle
Projecttitle
A Novel Class of Drug Treatment Against Chronic Constipation in Spinal Cord-Injured People
Programtype2
Operating Grants
Orgnameinp2
Université Laval
Cihramount2
$160,000
Cihrequipment2
$0
Programname2
Proof of Principle Program - Phase I
Keyworddelim
Autonomic Function; Bowel Problems; Constipation; Drug Treatment; Spinal Cord Injury
Abstract
Spinal cord injury (SCI) is a devastating condition leading to immediate and irreversible paralysis below injury level. Patients with SCI suffer also from severe health problems including bladder and bowel dysfunctions. Although, some approaches or devices are currently used to treat occasional constipation in the general population, those same approaches are generally considered as inefficient or unsafe when chronically used against chronic constipation. We obtained evidence suggesting that some unsuspected classes of molecules could be used to trigger episodes of defecation in SCI patients. We propose experiments that will enable the selection of the best molecule(s)among them. This may pave the way to a novel class of pills specifically designed to safely and efficiently treat chronic constipation in SCI patients.
Competitiondate
201302
Approvedterm2
1 yr 0 mth
Pinamesdelim
Guertin, Pierre
Approvedterm
1 an 0 mois
Cihrcontribution2
~ $160,000~ $0~
Université Laval - $160,000 Grant (2012-13) | Canada Spends